AlphaCrest Capital Management’s HealthEquity HQY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-4,390
Closed -$270K 1316
2022
Q2
$270K Buy
4,390
+926
+27% +$59.3K 0.01% 1142
2022
Q1
$234K Buy
+3,464
New +$187K 0.01% 1171
2021
Q4
Sell
-4,425
Closed -$287K 1393
2021
Q3
$287K Buy
+4,425
New +$307K 0.01% 1124
2021
Q2
Sell
-11,615
Closed -$790K 1279
2021
Q1
$790K Buy
11,615
+4,032
+53% +$317K 0.04% 600
2020
Q4
$529K Buy
+7,583
New +$472K 0.04% 610
2020
Q2
Sell
-4,913
Closed -$249K 995
2020
Q1
$249K Sell
4,913
-5,664
-54% -$376K 0.03% 865
2019
Q4
$783K Buy
10,577
+4,377
+71% +$273K 0.06% 489
2019
Q3
$354K Sell
6,200
-7,500
-55% -$498K 0.02% 1054
2019
Q2
$896K Buy
13,700
+9,700
+243% +$675K 0.08% 453
2019
Q1
$296K Buy
+4,000
New +$281K 0.04% 663

Other funds holding HQY

AlphaCrest Capital Management's HQY Position: Q3 2022 in Review

AlphaCrest Capital Management sold out of HealthEquity (HQY) in Q3 2022, closing a stake of 4,390 shares — an estimated $270K sold.

AlphaCrest Capital Management first reported a position in HQY in Q1 2019 and held it in 10 quarters. The position peaked at $896K in Q2 2019. 310 funds tracked by Wall St. Rank hold HQY as of Q3 2022.

  • AlphaCrest Capital Management reported no remaining HealthEquity position as of Q3 2022 after selling out during the quarter.
  • AlphaCrest Capital Management sold 4,390 HealthEquity shares in Q3 2022, an estimated $270K.
  • AlphaCrest Capital Management first reported a position in HealthEquity in Q1 2019 and held it in 10 quarters.
  • AlphaCrest Capital Management's HealthEquity position peaked at $896K in Q2 2019.
  • 310 funds tracked by Wall St. Rank held HealthEquity as of Q3 2022.

Based on AlphaCrest Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.